三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
公司新冠疫苗ReCOV免疫原性位居行业前列(单位:IU/mL,Log10)
公司新冠疫苗ReCOV免疫原性位居行业前列(单位:IU/mL,Log10)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:214KB
图片尺寸:1830*729
同报告图片
/
4
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
所属报告:
瑞科生物-投资价值分析报告:自主研发为核心驱动力的疫苗Biotech-230106.pdf(44页)
打包全文图表
相关数据
考察不同的备选佐剂联合抗原的免疫原性差异
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
收藏
行业数据
2023-01-09
原图定位
查看详情
全球新冠疫苗:产能、免疫原性、保护力
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
收藏
行业数据
2022-07-11
原图定位
查看详情
新佐剂新冠肺炎疫苗ReCOV临床数据表现出高度差异化
fCDnl4Xmr5LkuK3lkozmipfkvZPmu7TluqYgKEdNVCwgOTUlIENJKSB8IEQ2MTRHIHwgRGVsdGEgfCBPbWljcm9uIHwKfCA6LS06IHwgOi0tOiB8IDotLTogfCA6LS06IHwKfCAyMSwyMTAgfCAxMyw3NjQgfCAzLDg2MSB8ICB8CnwgMiw2MjYgfCAxLDk3Mi4yIHwgMiwzNDguOCB8IDY5LDEwOCB8CnwgMjUsMzA2IHwgMTYsODMzIHwgIHwgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuCAyMDIxIOW5tOaKpeaaqOS4muWKoei/m+WxleS6pOa1geS8muaKlei1hOiAhea8lOekuuadkOaWme+8jOWNjuWuieivgeWIuOeglOeptuaJgA==
收藏
行业数据
2022-06-01
原图定位
查看详情
ReCOV与Moderna、Pfizer中和抗体GMT水平对比
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
收藏
行业数据
2022-05-25
原图定位
查看详情
RBD-linker-CTB融合蛋白免疫原性对比
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
收藏
行业数据
2022-02-24
原图定位
查看详情
6岁以上健康人群接种克威莎的安全性和免疫原性
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
收藏
行业数据
2022-02-24
原图定位
查看详情
免疫原性研究结果表明派格宾的中和抗体产生率显著低于派罗欣(罗氏)
收藏
行业数据
2020-11-12
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
ReCOV 可诱导高水平的中和抗体,并具有良好的免疫持久性。根据披露的新西兰 I期临床数据,以及菲律宾 II 期基础免疫临床数据。ReCOV 基础免疫可诱导高水平针对原型株真病毒的中和抗体,基线血清阴性人群中有更高的血清阳转率及较高的基线增长倍数,而基线血清阳性人群中有更高水平的中和抗体。此外,ReCOV 具有较好的安全性。根据I 期临床数据,大部分接种后发生的不良事件(TEAE)为轻度 (1 级),仅 8 例中度 TEAE(3例为 ADR)。
行业数据
原图定位
当前图表所属:
瑞科生物-投资价值分析报告:自主研发为核心驱动力的疫苗Biotech-230106.pdf(44页)
全球和中国已上市HPV疫苗
我国部分省市HPV疫苗接种优惠政策
HPV分型
2021年全球Top10疫苗产品及销售额
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》